BEGIN:VCALENDAR VERSION:2.0 PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN X-WR-TIMEZONE:Europe/London METHOD:PUBLISH BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0100 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20260930T083000 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:CiviCRM_EventID_1999_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com SUMMARY:BioWednesday Breakfast Cambridge: Overseas Capital and UK Life Sciences - Opportunity or Dependence X-ALT-DESC;FMTTYPE=text/html:

Finding s from Bidwells’ report Capital\, clusters and the scale-up gap show that overseas investors are not peripheral to UK life sciences scale-up funding. Since 2022\, 81% of UK life sciences growth capita l has come from rounds involving at least one fore ign investor\, with US investors involved in 69% o f that capital. Life sciences is also the largest of the sectors analysed\, accounting for £3.1bn of the £6.3bn total. For a company planning a growth round\, the question is rarely whether overseas c apital will be invovlved\, but on what terms. 

\n \n

The panel will explore what it means in p ractice when an overseas investor leads your round \, for governance\, for where the company builds i ts teams and labs\, and for whether it stays and g rows within its UK cluster. It will consider why l ife sciences is more exposed to foreign capital\, at greater scale\, than any other UK priority sect or\, and what that concentration means for the fun ding environment companies are raising into. Final ly\, the discussion will ask whether overseas fund ing\, or even acquisition\, is necessarily a bad o utcome\, whether for the company or for the UK\, o r whether the real question is how much economic v alue\, R&D activity\, talent and lab demand remain s anchored here

\n \n

Panel
\n Moderator: Sue Foxley\, Bidwells
\n Panellists:
\n •   Emily Pilkington\, Head of Life Science\, Healthcare and Planetary Health\, NatWest Venture Banking
\n •   Simon Amies\, Partner\, Cooley
\n Other panellists TBC

\n \n

Registration: 

\n \n

•    is Free for employees of One Nucleus membe r organisations
\n •    Non-members: £50 +VAT
\n •    Academics: please contact info@onenucleus.com

DESCRIPTION:Findings from Bidwells’ report Capital\, clusters and the scale-up gap show that overseas investors are not peripheral to UK life sciences scale-up fu nding. Since 2022\, 81% of UK life sciences growth capital has come from rounds involving at least o ne foreign investor\, with US investors involved i n 69% of that capital. Life sciences is also the l argest of the sectors analysed\, accounting for £3 .1bn of the £6.3bn total. For a company planning a growth round\, the question is rarely whether ove rseas capital will be invovlved\, but on what term s. \n \n \n \n The panel will explore what it mean s in practice when an overseas investor leads your round\, for governance\, for where the company bu ilds its teams and labs\, and for whether it stays and grows within its UK cluster. It will consider why life sciences is more exposed to foreign capi tal\, at greater scale\, than any other UK priorit y sector\, and what that concentration means for t he funding environment companies are raising into. Finally\, the discussion will ask whether oversea s funding\, or even acquisition\, is necessarily a bad outcome\, whether for the company or for the UK\, or whether the real question is how much econ omic value\, R&D activity\, talent and lab demand remains anchored here\n \n \n \n Panel\n \n Modera tor: Sue Foxley\, Bidwells\n \n Panellists:\n \n •    Emily Pilkington\, Head of Life Science\, Healt hcare and Planetary Health\, NatWest Venture Banki ng\n \n •   Simon Amies\, Partner\, Cooley\n \n Ot her panellists TBC\n \n \n \n Registration: \n \n \n \n •    is Free for employees of One Nucleus me mber organisations\n \n •    Non-members: £50 +VAT \n \n •    Academics: please contact info@onenucle us.com (mailto:info@onenucleus.com)\n \n CATEGORIES:Events CALSCALE:GREGORIAN DTSTAMP;TZID=Europe/London:20260930T083000 DTSTART;TZID=Europe/London:20260930T083000 DTEND;TZID=Europe/London:20260930T103000 LOCATION:Bidwell House\n Trumpington Road\n Trumpington\n C ambridge\, CB2 9LN\n United Kingdom\n URL:https://onenucleus.com/civicrm/event/info?reset=1&id=1999 END:VEVENT END:VCALENDAR